 <h1>Inqovi Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>cedazuridine / decitabine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about cedazuridine / decitabine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Inqovi.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to cedazuridine / decitabine: oral tablet</i></p><h3>Warning</h3><p>Cedazuridine and decitabine affects your immune system.  You may get infections more easily, even serious or fatal infections.  Call your doctor if you have a fever, chills, cough, mouth sores, or unusual bleeding or bruising.</p><p>Get emergency medical help if you have signs of an allergic reaction:  hives; difficult breathing; swelling of your face, lips, tongue, or throat.</p><p>Call your doctor at once if you have:</p><ul>
<li>
<p>easy bruising, unusual bleeding, purple or red spots under your skin;</p>
</li>
<li>
<p>low red blood cells (anemia)--pale skin, unusual tiredness, feeling light-headed or short of breath, cold hands and feet;</p>
</li>
<li>
<p>low white blood cell counts--fever, mouth sores, skin sores, sore throat, cough, trouble breathing; or</p>
</li>
<li>
<p>signs of a lung infection--fever, chills, cough with mucus, chest pain, feeling short of breath.</p>
</li>
</ul><p>easy bruising, unusual bleeding, purple or red spots under your skin;</p><p>low red blood cells (anemia)--pale skin, unusual tiredness, feeling light-headed or short of breath, cold hands and feet;</p><p>low white blood cell counts--fever, mouth sores, skin sores, sore throat, cough, trouble breathing; or</p><p>signs of a lung infection--fever, chills, cough with mucus, chest pain, feeling short of breath.</p><p>Your treatments may be delayed or permanently discontinued if you have certain side effects.</p><p>Common side effects may include:</p><ul>
<li>
<p>fever, low blood cell counts;</p>
</li>
<li>
<p>bruising or bleeding;</p>
</li>
<li>
<p>abnormal liver function tests;</p>
</li>
<li>
<p>headache, dizziness, feeling tired;</p>
</li>
<li>
<p>swelling in your arms or legs;</p>
</li>
<li>
<p>muscle or joint pain;</p>
</li>
<li>
<p>painful mouth sores;</p>
</li>
<li>
<p>shortness of breath, lung infection;</p>
</li>
<li>
<p>nausea, loss of appetite;</p>
</li>
<li>
<p>diarrhea, constipation;</p>
</li>
<li>
<p>rash; or</p>
</li>
<li>
<p>cold symptoms such as stuffy nose, sneezing, cough, sore throat.</p>
</li>
</ul><p>fever, low blood cell counts;</p><p>bruising or bleeding;</p><p>abnormal liver function tests;</p><p>headache, dizziness, feeling tired;</p><p>swelling in your arms or legs;</p><p>muscle or joint pain;</p><p>painful mouth sores;</p><p>shortness of breath, lung infection;</p><p>nausea, loss of appetite;</p><p>diarrhea, constipation;</p><p>rash; or</p><p>cold symptoms such as stuffy nose, sneezing, cough, sore throat.</p><p>This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to cedazuridine / decitabine: oral tablet</i></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Thrombocytopenia (82%) Grade 3 or 4 occurring in 76%, leukocytes decreased (87%), platelet count decreased (82%), neutropenia (73%) with Grade 3 or 4 occurring in 71%.  anemia (71%) with Grade 3 or 4 occurring in 55%, hemorrhage (e.g., contusion, epistaxis, petechiae, hematuria, conjunctival hemorrhage, mouth hemorrhage, purpura, angina bullosa hemorrhagica, gingival bleeding, hematoma, hemoptysis, eye contusion, hemorrhagic diathesis, increased tendency to bruise, vaginal hemorrhage, abdominal wall hematoma, blood blister, bone contusion, catheter site bruise, ecchymosis, genital hemorrhage, abdominal hematoma, oral mucosa hematoma, periorbital hemorrhage, procedural hemorrhage, pulmonary alveolar hemorrhage, retinal hemorrhage, scleral hemorrhage, thrombotic thrombocytopenic purpura, tongue hemorrhage, vessel puncture site hemorrhage) (43%), febrile neutropenia (33%)<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Sepsis (e.g., sepsis, bacteremia, septic shock, endocarditis, pseudomonal bacteremia, staphylococcal bacteremia) (14%), cellulitis (e.g., cellulitis, catheter site cellulitis, infected bite) (12%)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Myalgia (e.g., myalgia, pain in extremity, muscle spasms, pain, musculoskeletal pain, non-cardiac chest pain, muscular weakness,</p><p>musculoskeletal chest pain, flank pain, musculoskeletal stiffness, muscle strain, musculoskeletal discomfort (42%), arthralgia (e.g., arthralgia, back pain, neck pain, joint stiffness, pain in jaw, joint swelling, bursitis, joint range of motion decreased, joint injury (40%)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Glucose increased (54%), sodium decreased (30%), calcium decreased (30%), anorexia (24%), weight loss (10%)</p><p><b>Uncommon</b> (0.1% to 1%): Tumor lysis syndrome<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (12%)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Transaminase increased (e.g., alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, liver function test increased, transaminases increased) (21%), abdominal pain (e.g., abdominal pain upper, abdominal pain lower, epigastric discomfort, abdominal discomfort) (19%), vomiting (15%)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (e.g., dyspnea, dyspnea exertional, hypoxia, wheezing, chronic obstructive pulmonary disease, tachypnea (38%) cough (e.g., cough, productive cough) (28%), upper respiratory tract infection (e.g., upper respiratory tract infection, nasopharyngitis, sinusitis, viral upper respiratory tract infection) (23%), pneumonia (e.g., pneumonia, pneumonitis, atypical pneumonia, lung infection) (21%)</p><p><b>Postmarketing reports</b>: Interstitial lung disease (decitabine)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue/asthenia/lethargy (55%), edema (e.g., edema peripheral, peripheral swelling, swelling face, fluid overload, localized edema, face edema, edema, eye swelling, eyelid edema, fluid retention, periorbital swelling, scrotal edema, scrotal swelling) (30%), pyrexia (19%), fall (12%)<sup>[Ref]</sup></p><h3>General</h3><p>Myelosuppression (e.g., thrombocytopenia, neutropenia, anemia, febrile neutropenia) is the most frequent cause of dose reduction or interruption, occurring in 36% of patients.  Permanent discontinuation due to myelosuppression (febrile neutropenia) occurred in 1% of patients.  Myelosuppression and worsening neutropenia may occur more frequently in the first or second treatment cycles and may not necessarily indicate progression of underlying MDS.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (e.g., dizziness, vertigo, postural dizziness, positional vertigo) (33%), headache (e.g., headache, sinus pain, sinus headache) (30%), neuropathy (e.g., hypoesthesia, paresthesia, neuropathy peripheral, gait disturbance, peripheral sensory neuropathy, ataxia, balance disorder, brachial plexopathy, carpal tunnel syndrome, radicular pain) (13%)<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Renal impairment (e.g., blood creatinine increased, acute kidney injury, blood urea increased, blood creatine increased, renal failure) (18%)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypotension (e.g., hypotension, blood pressure decreased, cardiogenic shock) (11%), arrhythmia (e.g., sinus tachycardia, atrial fibrillation, bradycardia, tachycardia, atrial flutter, sinus bradycardia, conduction disorder) (11%)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (e.g., maculopapular rash, rash, erythema, skin lesion, folliculitis, dermatitis, dermatitis acneiform, eczema, erythema multiforme, rash erythematous, seborrheic keratosis, skin ulcer, dermatitis allergic, dermatitis contact, eczema nummular, genital erythema, rash</p><p>papular, rash pruritic, rash pustular, seborrheic dermatitis, skin exfoliation, skin irritation, stasis dermatitis, ulcerative keratitis (33%) </p><p><b>Common</b> (1% to 10%): Acute febrile neutrophilic dermatosis (Sweet's syndrome)</p><p><b>Postmarketing reports</b>: Differentiation syndrome (decitabine)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Constipation (44%), mucositis (e.g., oropharyngeal pain, stomatitis, mouth ulceration, proctalgia, oral pain, gingivitis, oral disorder, gingival pain, colitis, glossodynia, mouth swelling, pharyngitis, proctitis, duodenitis, enteritis, gingival discomfort, gingival swelling, lip disorder, lip</p><p>ulceration, mucosal ulceration, nasal ulcer, noninfective gingivitis, oral mucosal blistering, oral mucosal erythema, pharyngeal erythema, pharyngeal ulceration, tongue ulceration, vulvitis) (41%), nausea (40%), diarrhea (37%)<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Inqovi (cedazuridine-decitabine)." Taiho Oncology, Inc., Princeton, NJ. </p><h2>More about Inqovi (cedazuridine / decitabine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: antineoplastic combinations</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Inqovi &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Myelodysplastic Syndrome</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>